Big League Politics

Big League Politics

Share this post

Big League Politics
Big League Politics
Dr. McCullough Weighs In: The History & Future of GLP-1s
Copy link
Facebook
Email
Notes
More

Dr. McCullough Weighs In: The History & Future of GLP-1s

Big League Politics's avatar
Big League Politics
Mar 31, 2025
∙ Paid
4

Share this post

Big League Politics
Big League Politics
Dr. McCullough Weighs In: The History & Future of GLP-1s
Copy link
Facebook
Email
Notes
More
Share

In a recent article by Dr. Peter McCullough, he explores the evolution of GLP-1 receptor agonists and their expanding role beyond diabetes treatment.

The journey began in 2005 with the FDA approval of exenatide (Byetta), setting the stage for a new class of medications that regulate blood sugar and appetite.

A Timeline of GLP-1 Advancements:

2005 – Exenati…

Keep reading with a 7-day free trial

Subscribe to Big League Politics to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Big League Politics
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More